CARMAT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.15 EUR | -2.63% |
|
-17.21% | -52.99% |
| Mar. 25 | Carmat: final agreement with creditors | CF |
| Mar. 25 | Carmat Secures Two-year Extensions for Bank Loans | MT |
Presenter SpeechStéphane Piat (Executives)Good morning, good evening to everybody, and welcome...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.15
EUR
Average target price
14.22
EUR
Spread / Average Target
+351.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -52.99% | 83.34M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Transcript : Carmat SA - Special Call
